viernes, 2 de agosto de 2019

Cystic Fibrosis News Today Weekly Digest

Advertisement 

Cystic Fibrosis Weekly Update

Contents:

Long-term Treatment with Kalydeco Decreases Risk of Lung Infection, Study Reports

Aug 02, 2019 07:00 am | Patricia Inacio, PhD



 KalydecoTreatment for three years with Kalydeco (ivacaftor) reduces the risk of lung infection by serious pathogens — including Pseudomonas aeruginosa and Staphylococcus aureus — in people with cystic fibrosis (CF), a U.K. study reports. The study, “Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens: A Cohort Study Using National Registry Data,” was published […]
The post Long-term Treatment with Kalydeco Decreases Risk of Lung Infection, Study Reportsappeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Long-term Treatment with Kalydeco Decreases Risk of Lung Infection, Study Reports on Facebook

Rare Disease Groups Seek Public Support to Renew Newborn Screening Act in Senate

Aug 01, 2019 06:10 pm | Grace Frank



Newborn screening actScreening newborns for genetic diseases with treatments that can prevent crippling or deadly progression, especially for rare disorders, has a ways to go in the United States. No state today tests for all 35 disorders recommended under a federal screening panel, and even in those that come close, rare diseases can fall to competing priorities. […]
The post Rare Disease Groups Seek Public Support to Renew Newborn Screening Act in Senateappeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Rare Disease Groups Seek Public Support to Renew Newborn Screening Act in Senate on Facebook

Let’s Talk About Money: Dollars and Disabilities in the Workplace

Aug 01, 2019 09:00 am | Elly Aylwin-Foster



moneyA common perception about those with disabilities is that when they find a job, they are so appreciative that they are the most dedicated, loyal employees in the building. A recurring theme in conversations that I’ve had about working with chronic illness is that those of us with a disability are often so thankful to […]
The post Let’s Talk About Money: Dollars and Disabilities in the Workplace appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Let’s Talk About Money: Dollars and Disabilities in the Workplace on Facebook

Oklahoma Ranks Lowest on Programs Key to Rare Diseases on NORD’s 2019 State Report Card

Aug 01, 2019 07:15 am | Larry Luxner



Jade Day, OklahomaOklahoma suffers more tornadoes than any other state, has the highest per-capita rate of women in U.S. prisons, ranks second in the number of teen births per 100,000 teenage girls, and has the nation’s third-highest rate of uninsured residents — with 13.9% of all Oklahomans lacking health coverage. As if that’s not enough, the Sooner […]
The post Oklahoma Ranks Lowest on Programs Key to Rare Diseases on NORD’s 2019 State Report Card appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Oklahoma Ranks Lowest on Programs Key to Rare Diseases on NORD’s 2019 State Report Card on Facebook

Using Nebulizer While Lying on Alternating Sides Can Better Deposit Therapy Across Lungs, Trial Finds

Aug 01, 2019 07:00 am | Alice Melão



nebulizationPeople using a nebulizer while lying on their side showed no significant loss in a treatment’s overall deposition in the lungs, a study in healthy adults and in cystic fibrosis (CF) patients reports. Rather, it found that alternating sides instead of sitting upright may better deposit a medicine’s active compounds throughout the lungs, especially across […]
The post Using Nebulizer While Lying on Alternating Sides Can Better Deposit Therapy Across Lungs, Trial Finds appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Using Nebulizer While Lying on Alternating Sides Can Better Deposit Therapy Across Lungs, Trial Finds on Facebook
Advertisement 

Recent News

Development Bank of Wales Raises Funds for UK’s Cystic Fibrosis Trust
Do You Feel What I Feel?
Proteostasis Begins Dosing in Phase 2 Trial of 3 CF Investigational Therapies
I Am Not a Morning Person
The Long-term Effect of Disability Language

No hay comentarios:

Publicar un comentario